News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-06 5:3:2 am Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate Update PRNewsWire
2024-03-05 1:30:0 pm Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024 PR Newswire
2024-03-01 1:8:0 pm Aadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComa PR Newswire
2024-02-26 1:5:0 pm Aadi Bioscience to Present at the TD Cowen 44th Annual Healthcare Conference PR Newswire
2024-01-26 1:5:0 pm Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium PR Newswire
2024-01-19 1:5:0 pm Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium PR Newswire
2023-12-14 1:5:0 pm Aadi Bioscience Reports Interim Results from PRECISION1 Trial of nab-Sirolimus Demonstrating Anti-Tumor Activity in Solid Tumors with TSC1 or TSC2 Inactivating Alterations PR Newswire
2023-12-13 3:12:16 am Aadi Bioscience, Inc. (NASDAQ:AADI) is definitely on the radar of institutional investors who own 39% of the company Simply Wall St.
   

Please consider a small donation if you think this website provides you with relevant information